Profile: Calmune Corporation is a biotechnology company developing antibody therapeutics to address unmet clinical needs for the betterment of human health. Our Sebvi™ technology is used to efficiently recover human antibodies from Epstein barr virus transformed memory B cells, and it is also used to mine the natural human immune response to routinely & rapidly isolate fully human, biologically potent antibodies. Our AC-8 has completed its discovery phase, and is now undergoing preclinical testing to evaluate the therapeutic potential of topically administered AC-8 in preventing the onset of ocular keratitis following HSV infection.